Delcath To Establish Galway Headquarters

A speciality pharmaceutical and medical device company, is to establish its European Headquarters in Galway.

The investment by Delcath is supported by the Irish Government with the aid of IDA Ireland.

The establishment of the new operation will support the company’s commercial launch of its Hepatic Chemosat Delivery System in Europe.

With a broad indication for the administration of melphalan hydrochloride to the liver, the Hepatic Chemosat Delivery System may ultimately fulfill an annual unmet clinical need for as many as 100,000 patients with cancers in the liver across 30 European countries.

Delcath Systems Limited will create a number of jobs in the areas of marketing, sales and logistic support and recruitment of staff is currently underway with the new headquarters expected to be fully operational by the final quarter of 2011.

Announcing the decision by Delcath, Minister for Jobs, Enterprise and Innovation, Richard Bruton said: “If we are to get out of this crisis and get jobs and the economy growing again, we must build relentlessly on our strengths. One aspect of this is our attractiveness as a location of high-value foreign direct investment and our established base of high-tech companies. We must tirelessly build on these advantages not only to attract further companies but also to achieve spin-off benefits for Irish start-ups and researchers.

“Today’s announcement that another pharmaceutical and medical device company is locating its European headquarters in Ireland with the creation of jobs is great news for Galway and for the wider economy. I am determined to build on this so that today’s announcement can be replicated across the economy in the coming years”.

(BMcN)